eHealth, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EHTH research report →
Range $1.75 – $2
Price Chart
About the company
eHealth, Inc. operates a digital health insurance marketplace within the United States, dedicated to engaging consumers, educating them, and simplifying the health insurance enrollment process. Its operations are categorized into two main divisions: Medicare offerings, and policies tailored for individuals, families, and small enterprises.
- CEO
- Derrick Anthony Duke
- IPO
- 2006
- Employees
- 1,665
- HQ
- Indianapolis, IN, US
Get TickerSpark's AI analysis on EHTH
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.25M
- P/E
- -0.37
- Fwd P/E
- 0.28
- PEG
- 0.00
- P/S
- 0.02
- P/B
- 0.01
- EV/EBITDA
- 1.33
- Div Yield
- 0.00%
- Gross Margin
- 98.62%
- Op Margin
- 11.93%
- Net Margin
- 4.89%
- ROE
- 2.70%
- ROIC
- 3.34%
Latest fiscal year · YoY change
- Revenue
- $554.01M+4.1%
- Gross Profit
- $540.25M+1.8%
- Op Income
- $68.50M
- Net Income
- $40.04M+298.2%
- EPS
- $1.31+210.1%
- OCF Growth
- -38.0%
- FCF Growth
- -30.2%
- 52W High
- $5.35
- 52W Low
- $0.32
- 50D MA
- $0.63
- 200D MA
- $1.31
- Beta
- 1.59
- RSI (14)
- 28
- Avg Volume
- 436.28K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
eHealth said Q3 was in line with expectations as it kept cutting costs, improved cash flow, and laid groundwork for a 2027 return to growth under its Lifetime Advisory Model.· November 4, 2026
- Q3 revenue was $21.3 million, with GAAP net loss of $35.9 million and adjusted EBITDA loss of $39.9 million.
- Management said operating cash flow improved to $19.6 million for the first 9 months of 2026, nearly doubling from $10.6 million a year ago.
- Cost actions were a major theme: fixed costs fell 17%, total marketing and advertising expense declined 55%, and total operating costs and expenses declined 29%.
- The company sees early signs the Lifetime Advisory Model is working, including ancillary cross-sell above 40% and better first-90-day retention on policies sold by career advisers.
- Management reaffirmed 2026 guidance, raised expected 2026 net adjustment revenue to $17 million-$20 million, and reiterated a goal of mid-single-digit revenue growth in 2027 with expanded margins and positive operating cash flow.
Q3 2026 revenue was $21.3 million. GAAP net loss was $35.9 million, and adjusted EBITDA loss was $39.9 million. Medicare segment revenue was $18.1 million, down 64% year over year; Medicare segment gross loss was $12.7 million versus $1.2 million a year ago; Medicare tail revenue was $1.5 million versus $12.1 million; and Employer and Individual revenue was $3.2 million versus $3.9 million. Third-quarter operating cash flow was negative $11.2 million, improving by $14.1 million from negative $25.3 million. For the first 9 months, operating cash flow was $19.6 million versus $10.6 million, and the company ended the quarter with $88.1 million in cash, cash equivalents and short-term marketable securities. Management reaffirmed fiscal 2026 guidance ranges and updated 2026 net adjustment revenue to $17 million-$20 million from $16 million-$20 million after recognizing $1.4 million of tail revenue in Q3.
Derrick Duke framed the quarter as evidence that eHealth is executing on three priorities: the Lifetime Advisory Model, better cash flow, and a setup for sustainable growth starting next year. He emphasized that the company intentionally shifted Medicare marketing outside the main enrollment windows to maximize returns and preserve adviser capacity for existing members, and said early AEP demand looks strong. He was upbeat on carrier relationships, sponsorship revenue recovery, and the new BPO deal with a top 3 Medicare carrier, while also pointing to CHOICE/ICHRA as a longer-term diversification opportunity.
John Dolan focused on the financial impact of the company’s cost actions and the seasonal nature of the business under the new model. He cited 73% lower Medicare variable marketing and advertising expense, 24% lower Medicare customer care and enrollment expense, a 17% decline in combined G&A and technology/content expense, and a 29% decline in total operating costs and expenses. He also said the company is on track for more than $60 million of total 2026 cost savings and about $30 million of fixed cost savings, while liquidity remains supported by $88.1 million of cash and a large commissions receivable balance of $970.6 million.
Analysts focused on why margins may expand in Q4 despite lower revenue, early AEP volumes, carrier growth mandates, the effect of election-related advertising on spend timing, the economics of the BerniePortal partnership, and how to interpret the 2% decline in Medicare Advantage LTV. Management said margin improvement is being driven by reduced marketing spend, cost discipline, and AI tools that are lowering administrative costs, and noted early cost-per-call and cost-per-visit metrics are favorable. On carrier demand, management said partners are asking for growth in specific plan types and geographies, and that Amplify can provide flexible licensed-agent capacity. They also clarified that the cited LTV excludes ancillary products, and said ancillary offerings like senior dental and hospital indemnity could add roughly $200 and $300 of value, respectively, on top of MA LTV.
The call presented a clearer path to cash generation, with operating cash flow up sharply year to date and management expecting Q4 to improve versus last year. Early signs from the Lifetime Advisory Model were encouraging, including ancillary cross-sell above 40%, better early retention, and strong initial AEP demand. Management also pointed to carrier interest, recovering sponsorship revenue, and new partnerships as signs the platform may be better positioned for a 2027 growth inflection.
Core Medicare revenue fell sharply, with applications down 55% and Medicare segment revenue down 64%, reflecting the company’s deliberate pullback in marketing and seasonally lower volume. Tail revenue was much lower year over year, and Medicare segment gross loss widened materially. Management also acknowledged that the most important weeks of AEP are still ahead, and that the company remains in discussions with H.I.G. about capital structure, which could matter as the preferred redemption date approaches in April 2027.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 88.3%
- Shares Outstanding
- 32.36M
- Float Shares
- 28.57M
of shares held by institutions
107 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| 8 Knots Management, LLC | 2.33M | 0 |
| Aqr Capital Management LLC | 2.29M | ▲ 573.30K |
| Nantahala Capital Management, LLC | 1.76M | 0 |
| Vanguard Group Inc | 1.51M | ▼ 14.57K |
| Palo Alto Investors LP | 1.48M | 0 |
| Blackrock, Inc. | 1.34M | ▼ 1.35M |
| Vanguard Capital Management LLC | 1.18M | ▼ 25.96K |
| Acadian Asset Management LLC | 589.02K | ▲ 388.67K |
| D. E. Shaw & Co., Inc. | 568.23K | ▲ 98.68K |
| Redwood Capital Management, LLC | 467.39K | 0 |
| Goldman Sachs Group Inc | 447.45K | ▲ 4.57K |
| Eversept Partners, LP | 404.85K | ▲ 183.94K |
Held by 44 ETFs
Biggest fund positions in EHTH by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 10, 26 | Galimi Gavin G. | other | 842 |
| Oct 10, 26 | Barbeau Michelle Marie | other | 323 |
| Oct 10, 26 | Dolan John Joseph | other | 465 |
| Oct 1, 26 | SOISTMAN FRANCIS S JR | sell | 20,306 |
| Oct 2, 26 | SOISTMAN FRANCIS S JR | sell | 20,306 |
| Sep 10, 26 | Barbeau Michelle Marie | other | 4,312 |
| Sep 10, 26 | Dolan John Joseph | other | 5,859 |
| Sep 1, 26 | Barbeau Michelle Marie | other | 70,000 |
| Sep 1, 26 | Dolan John Joseph | other | 70,000 |
| Sep 1, 26 | Galimi Gavin G. | other | 60,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EHTH coverage
Recent articles, reports, and earnings notes.
No research on EHTH yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EHTH report →Medicare Annual Enrollment Halftime Report: 75% of enrollees have used AI tools to review 2027 Medicare plans
prnewswire.com · Nov 19
48% of Medicare Beneficiaries Skipped or Delayed Care Because They Didn’t Understand Their Coverage. Another 54% Worried About Out-of-Pocket Costs
247wallst.com · Nov 11
eHealth, Inc. (EHTH) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 4
eHealth (EHTH) Reports Q3 Loss, Lags Revenue Estimates
zacks.com · Nov 4
eHealth, Inc. Announces Third Quarter 2026 Results
prnewswire.com · Nov 4
Health Insurance Open Enrollment Survey: 57% of Americans Say Picking a Health Plan Is Stressful
prnewswire.com · Oct 28
eHealth, Inc. to Hold Third Quarter 2026 Earnings Call on November 4 at 5:00 p.m. Eastern Time
prnewswire.com · Oct 21
Head to Head Analysis: eHealth (NASDAQ:EHTH) & Globe Life (NYSE:GL)
defenseworld.net · Oct 16
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.